EMBC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EMBC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Embecta's Enterprise Value is $2,053 Mil. Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $159 Mil. Therefore, Embecta's EV-to-EBIT for today is 12.88.
The historical rank and industry rank for Embecta's EV-to-EBIT or its related term are showing as below:
During the past 5 years, the highest EV-to-EBIT of Embecta was 14.71. The lowest was 5.04. And the median was 11.13.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Embecta's Enterprise Value for the quarter that ended in Mar. 2024 was $2,101 Mil. Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $159 Mil. Embecta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.59%.
The historical data trend for Embecta's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta Annual Data | |||||||||||
Trend | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | ||||||
EV-to-EBIT | - | - | - | 9.76 | 10.23 |
Embecta Quarterly Data | ||||||||||||||||
Sep19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
EV-to-EBIT | Get a 7-Day Free Trial | 13.18 | 14.68 | 10.23 | 14.04 | 13.18 |
For the Medical Instruments & Supplies subindustry, Embecta's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Embecta's EV-to-EBIT falls into.
Embecta's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 2053.417 | / | 159.4 | |
= | 12.88 |
Embecta's current Enterprise Value is $2,053 Mil.
Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $159 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta (NAS:EMBC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Embecta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) | = | EBIT | / | Enterprise Value (Q: Mar. 2024 ) |
= | 159.4 | / | 2101.166778 | |
= | 7.59 % |
Embecta's Enterprise Value for the quarter that ended in Mar. 2024 was $2,101 Mil.
Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $159 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Embecta's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
David F Melcher | director | 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102 |
Devdatt Kurdikar | officer: President and CEO | ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
Jacob Elguicze | officer: Chief Financial Officer | ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
Jeffrey Z Mann | officer: SVP, GC, Head Corp. Dev., Secy | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Jean Casner | officer: Chief Human Resources Officer | 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Karen Prange | director | 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316 |
Ajay Kumar | officer: SVP and CHRO | C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
Shaun Curtis | officer: SVP, Global Manuf./Sup. Chain | C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
David Albritton | director | ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880 |
Milton Mayo Morris | director | 2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019 |
Brian Capone | officer: VP, CAO & Corp. Controller | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Carrie L Anderson | director | 3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515 |
Claire Pomeroy | director | BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
Christopher R Reidy | director | ONE ADP BLVD, ROSELAND NJ 07068 |
Robert J. Hombach | director | C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015 |
From GuruFocus
By GuruFocus Research • 12-01-2023
By sperokesalga sperokesalga • 05-15-2023
By Stock market mentor Stock market mentor • 02-04-2023
By sperokesalga sperokesalga • 04-20-2023
By sperokesalga sperokesalga • 05-12-2023
By Marketwired • 08-08-2023
By GlobeNewswire • 12-14-2023
By Marketwired • 10-25-2023
By Stock market mentor Stock market mentor • 01-25-2023
By PRNewswire PRNewswire • 01-20-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.